Article
Identification of a Metabolism-Related Risk Signature to Predict the Outcome and Immune Infiltration of Esophageal Squamous Cell Carcinoma
2020-12-02
Abstract excerpt
<h4>Background: </h4> Metabolic reprogramming is associated with tumor heterogeneity and progression. Understanding the characteristics of metabolic reprogramming in esophageal squamous cell carcinoma (ESCC) might help us to uncover new biomarkers for patient outcomes and targets for therapies. <h4>Methods: </h4>: In this study, metabolism-related genes were screened from mRNA microarray data (GSE53624, GSE53622)....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 00a60cd1-6120-550f-9c74-65fea47734ff
- DOI
- 10.21203/rs.3.rs-117701/v1
